{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T08:50:04Z","timestamp":1792227004141,"version":"4.4.0"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1053\/j.ajkd.2013.10.048","type":"journal-article","created":{"date-parts":[[2014,1,21]],"date-time":"2014-01-21T21:30:27Z","timestamp":1390339827000},"page":"S39-S62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":292,"special_numbering":"S2","title":["Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease"],"prefix":"10.1053","volume":"63","author":[{"given":"Richard J.","family":"MacIsaac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif I.","family":"Ekinci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Jerums","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1053\/j.ajkd.2013.10.048_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2337\/db08-1543","article-title":"The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes","volume":"58","author":"Groop","year":"2009","journal-title":"Diabetes"},{"issue":"11","key":"10.1053\/j.ajkd.2013.10.048_bib2","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00125-010-1860-3","article-title":"In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"53","author":"Orchard","year":"2010","journal-title":"Diabetologia"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/xJAHA.111.000059","article-title":"Mortality rates in trials of subjects with type 2 diabetes","volume":"1","author":"Barkoudah","year":"2012","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9844","key":"10.1053\/j.ajkd.2013.10.048_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/MNH.0b013e3283456546","article-title":"Diabetic kidney disease with and without albuminuria","volume":"20","author":"MacIsaac","year":"2011","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO\u00a0Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MNH.0b013e3283293db1","article-title":"Early nephropathy in type 1 diabetes: the importance of early renal function decline","volume":"18","author":"Perkins","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"10","key":"10.1053\/j.ajkd.2013.10.048_bib8","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1007\/s00125-010-1794-9","article-title":"The clinical significance of hyperfiltration in diabetes","volume":"53","author":"Jerums","year":"2010","journal-title":"Diabetologia"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/ki.2012.189","article-title":"The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end-stage renal disease","volume":"82","author":"Skupien","year":"2012","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib10","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"issue":"6865","key":"10.1053\/j.ajkd.2013.10.048_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"issue":"20","key":"10.1053\/j.ajkd.2013.10.048_bib12","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1001\/jama.288.20.2579","article-title":"Molecular understanding of hyperglycemia's adverse effects for diabetic complications","volume":"288","author":"Sheetz","year":"2002","journal-title":"JAMA"},{"issue":"11","key":"10.1053\/j.ajkd.2013.10.048_bib13","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s001250100000","article-title":"Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy","volume":"44","author":"Cooper","year":"2001","journal-title":"Diabetologia"},{"issue":"7258","key":"10.1053\/j.ajkd.2013.10.048_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"issue":"14","key":"10.1053\/j.ajkd.2013.10.048_bib15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib16","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00125-011-2404-1","article-title":"Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds","volume":"55","author":"Zoungas","year":"2012","journal-title":"Diabetologia"},{"issue":"25","key":"10.1053\/j.ajkd.2013.10.048_bib17","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"de Boer","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"9131","key":"10.1053\/j.ajkd.2013.10.048_bib18","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"15","key":"10.1053\/j.ajkd.2013.10.048_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2013.10.048_bib20","doi-asserted-by":"crossref","unstructured":"Perkovic V, Heerspink HL, Chalmers J, et\u00a0al. Intensive glucose control improves kidney outcomes in patients with type 2 diabetes [published online ahead of print March 20, 2013]. Kidney Int. http:\/\/dx.doi.org\/10.1038\/ki.2012.401.","DOI":"10.1038\/ki.2012.401"},{"issue":"suppl","key":"10.1053\/j.ajkd.2013.10.048_bib21","first-page":"1163","article-title":"Sustained improvement of hemoglobin A1c reduces risk of end-stage renal disease in patients with type 1 diabetes and proteinuria","volume":"23","author":"Skupien","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2013.10.048_bib22","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinternmed.2011.2230","article-title":"Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis intensive glucose control in type 2 diabetes","volume":"172","author":"Coca","year":"2012","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.048_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM199807093390202","article-title":"Reversal of lesions of diabetic nephropathy after pancreas transplantation","volume":"339","author":"Fioretto","year":"1998","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.2215\/CJN.02560607","article-title":"Genetic factors in diabetic nephropathy","volume":"2","author":"Freedman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.048_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MNH.0b013e328350313e","article-title":"Towards understanding the inherited susceptibility for nephropathy in diabetes","volume":"21","author":"Thomas","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.ajkd.2007.10.029","article-title":"Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease","volume":"51","author":"Bleyer","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib27","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1440-1797.2012.01592.x","article-title":"Meta-analysis of the relationship between ACE I\/D gene polymorphism and end-stage renal disease in patients with diabetic nephropathy","volume":"17","author":"Yu","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.ki.5000023","article-title":"A\u00a0genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes","volume":"69","author":"Krolewski","year":"2006","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2013.10.048_bib29","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.2337\/db09-0641","article-title":"Confirmation of genetic associations at ELMO1 in the GoKinD collection supports its role as a susceptibility gene in diabetic nephropathy","volume":"58","author":"Pezzolesi","year":"2009","journal-title":"Diabetes"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/nrneph.2010.55","article-title":"Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms","volume":"6","author":"Tonna","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.4161\/epi.6.1.13362","article-title":"DNA methylation profiling identifies epigenetic differences between diabetes patients with ESRD and diabetes patients without nephropathy","volume":"6","author":"Sapienza","year":"2011","journal-title":"Epigenetics"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib32","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4161\/epi.6.4.14961","article-title":"Epigenetic regulation of somatic angiotensin-converting enzyme by DNA methylation and histone acetylation","volume":"6","author":"Riviere","year":"2011","journal-title":"Epigenetics"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib33","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00125-009-1268-0","article-title":"Is hyperfiltration associated with the future risk of developing diabetic nephropathy? A meta-analysis","volume":"52","author":"Magee","year":"2009","journal-title":"Diabetologia"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib34","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2337\/dc08-1560","article-title":"Renal hyperfiltration and the development of microalbuminuria in type 1 diabetes","volume":"32","author":"Ficociello","year":"2009","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.2215\/CJN.07610711","article-title":"Early renal function decline in type 2 diabetes","volume":"7","author":"Pavkov","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2013.10.048_bib36","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.2337\/dc11-2189","article-title":"Glomerular hyperfiltration and renal disease progression in type 2 diabetes","volume":"35","author":"Ruggenenti","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib37","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1532-5415.1985.tb07117.x","article-title":"Longitudinal studies on the rate of decline in renal function with age","volume":"33","author":"Lindeman","year":"1985","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib38","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2006080872","article-title":"Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes","volume":"18","author":"Perkins","year":"2007","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2013.10.048_bib39","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/dc09-1098","article-title":"Development and progression of renal insufficiency with and without albuminuria in adults with type 1 diabetes in the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications Study","volume":"33","author":"Molitch","year":"2010","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.048_bib40","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/diabetes.49.9.1399","article-title":"The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?","volume":"49","author":"Caramori","year":"2000","journal-title":"Diabetes"},{"issue":"11","key":"10.1053\/j.ajkd.2013.10.048_bib41","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1093\/ndt\/gfh470","article-title":"Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria","volume":"19","author":"Gaede","year":"2004","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.048_bib42","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2337\/dc11-0324","article-title":"Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial","volume":"34","author":"Hellemons","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib43","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1159\/000117461","article-title":"Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis","volume":"28","author":"Jerums","year":"2008","journal-title":"Am J Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2013.10.048_bib44","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.2337\/dc08-2151","article-title":"Higher levels of urinary albumin excretion within the normal range predict faster decline in glomerular filtration rate in diabetic patients","volume":"32","author":"Babazono","year":"2009","journal-title":"Diabetes Care"},{"issue":"30","key":"10.1053\/j.ajkd.2013.10.048_bib45","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta9300","article-title":"Systematic review on urine albumin testing for early detection of diabetic complications","volume":"9","author":"Newman","year":"2005","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib46","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0197-2456(97)00024-X","article-title":"Strengths and limitations of meta-analysis: larger studies may be more reliable","volume":"18","author":"Flather","year":"1997","journal-title":"Control Clin Trials"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib47","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1523-1755.2004.00585.x","article-title":"Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assay","volume":"65","author":"Comper","year":"2004","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2013.10.048_bib48","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1111\/j.1523-1755.2004.09219.x","article-title":"Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLC","volume":"92","author":"Brinkman","year":"2004","journal-title":"Kidney Int Suppl"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib49","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1053\/j.ajkd.2005.12.034","article-title":"Population prevalence of albuminuria in the Australian Diabetes, Obesity, and Lifestyle (AusDiab) Study: immunonephelometry compared with high-performance liquid chromatography","volume":"47","author":"Polkinghorne","year":"2006","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib50","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ki.2009.399","article-title":"In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria","volume":"77","author":"Perkins","year":"2010","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib51","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/diab.41.5.581","article-title":"Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion","volume":"41","author":"Lane","year":"1992","journal-title":"Diabetes"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib52","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diab.43.5.649","article-title":"Progressive decline in renal function in diabetic patients with and without albuminuria","volume":"43","author":"Tsalamandris","year":"1994","journal-title":"Diabetes"},{"issue":"24","key":"10.1053\/j.ajkd.2013.10.048_bib53","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1001\/jama.289.24.3273","article-title":"Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus","volume":"289","author":"Kramer","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diacare.27.1.195","article-title":"Nonalbuminuric renal insufficiency in type 2 diabetes","volume":"27","author":"MacIsaac","year":"2004","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1053\/j.ajkd.2013.10.048_bib55","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/jama.2010.884","article-title":"Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease","volume":"304","author":"Cooper-DeHoff","year":"2010","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2013.10.048_bib57","first-page":"S1","article-title":"Summary of revisions for the 2013 clinical practice recommendations","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1053\/j.ajkd.2013.10.048_bib58","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa013410","article-title":"Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes","volume":"347","author":"Lurbe","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib59","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.1464-5491.2000.00284.x","article-title":"Non-dipping circadian blood pressure and renal impairment are associated with increased mortality in diabetes mellitus","volume":"17","author":"Sturrock","year":"2000","journal-title":"Diabet Med"},{"issue":"7","key":"10.1053\/j.ajkd.2013.10.048_bib60","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/sj.ki.5000247","article-title":"Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease","volume":"69","author":"Agarwal","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/ajh.2011.168","article-title":"Thresholds of ambulatory blood pressure associated with chronic complications in type 2 diabetes","volume":"25","author":"Cardoso","year":"2012","journal-title":"Am J Hypertens"},{"issue":"11","key":"10.1053\/j.ajkd.2013.10.048_bib62","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/dc12-0306","article-title":"Low HDL cholesterol and the risk of diabetic nephropathy and retinopathy: results of the ADVANCE Study","volume":"35","author":"Morton","year":"2012","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib63","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1046\/j.1523-1755.2003.00164.x","article-title":"Lipoproteins in the DCCT\/EDIC cohort: associations with diabetic nephropathy","volume":"64","author":"Jenkins","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib64","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2215\/CJN.03691106","article-title":"Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors","volume":"2","author":"Ficociello","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ajkd.2013.10.048_bib65","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1007\/s00125-009-1541-2","article-title":"Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes","volume":"52","author":"Tolonen","year":"2009","journal-title":"Diabetologia"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib66","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04371206","article-title":"Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) Study","volume":"2","author":"Shepherd","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib67","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2009.03.022","article-title":"Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS)","volume":"54","author":"Colhoun","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2013.10.048_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2369-11-3","article-title":"Large kidneys predict poor renal outcome in subjects with diabetes and chronic kidney disease","volume":"11","author":"Rigalleau","year":"2010","journal-title":"BMC Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.048_bib69","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.2337\/db06-0592","article-title":"Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes","volume":"55","author":"Zerbini","year":"2006","journal-title":"Diabetes"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.048_bib70","doi-asserted-by":"crossref","first-page":"F617","DOI":"10.1152\/ajprenal.00278.2006","article-title":"A\u00a0role for AMP-activated protein kinase in diabetes-induced renal hypertrophy","volume":"292","author":"Lee","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib71","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1681\/ASN.2010010010","article-title":"Pathologic classification of diabetic nephropathy","volume":"21","author":"Tervaert","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.048_bib72","doi-asserted-by":"crossref","first-page":"506","DOI":"10.2337\/diabetes.51.2.506","article-title":"Cellular basis of diabetic nephropathy: 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes","volume":"51","author":"Caramori","year":"2002","journal-title":"Diabetes"},{"issue":"12","key":"10.1053\/j.ajkd.2013.10.048_bib73","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s001250050616","article-title":"Patterns of renal injury in NIDDM patients with microalbuminuria","volume":"39","author":"Fioretto","year":"1996","journal-title":"Diabetologia"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib74","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1440-1797.2011.01525.x","article-title":"Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria","volume":"17","author":"Okada","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"7","key":"10.1053\/j.ajkd.2013.10.048_bib75","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2337\/dc05-1788","article-title":"Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?","volume":"29","author":"MacIsaac","year":"2006","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib76","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2337\/diabetes.55.01.06.db05-0881","article-title":"Increased renal\u00a0arterial resistance predicts the course of renal function in type\u00a02 diabetes with microalbuminuria","volume":"55","author":"Nosadini","year":"2006","journal-title":"Diabetes"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib77","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1042\/CS20070261","article-title":"Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with type 2 diabetes","volume":"114","author":"Srivastava","year":"2008","journal-title":"Clin Sci (Lond)"},{"issue":"12","key":"10.1053\/j.ajkd.2013.10.048_bib78","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.2337\/dc11-1020","article-title":"Arterial stiffness is associated with incident albuminuria and decreased glomerular filtration rate in type 2 diabetic patients","volume":"34","author":"Bouchi","year":"2011","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib79","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2009050558","article-title":"Cerebral microvascular disease predicts renal failure in type 2 diabetes","volume":"21","author":"Uzu","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib80","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/ndt\/gfn716","article-title":"Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes","volume":"24","author":"Hanai","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1053\/j.ajkd.2013.10.048_bib81","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/00365510802187226","article-title":"Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) study","volume":"68","author":"Persson","year":"2008","journal-title":"Scand J Clin Lab Invest"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib82","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/j.1523-1755.2004.00868.x","article-title":"Low-molecular-weight AGEs are associated with GFR and anemia in\u00a0patients with type 2 diabetes","volume":"66","author":"Thomas","year":"2004","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib83","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/ki.2010.134","article-title":"Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy","volume":"78","author":"Penfold","year":"2010","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.048_bib84","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1172\/JCI11771","article-title":"Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice","volume":"108","author":"Yamamoto","year":"2001","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib85","doi-asserted-by":"crossref","first-page":"e35655","DOI":"10.1371\/journal.pone.0035655","article-title":"Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes","volume":"7","author":"Perkins","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib86","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000331064","article-title":"Advanced glycation urinary protein-bound biomarkers and severity of diabetic nephropathy in man","volume":"34","author":"Coughlan","year":"2011","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib87","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1681\/ASN.2007050556","article-title":"Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetics","volume":"19","author":"Wolkow","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib88","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2215\/CJN.03010608","article-title":"Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes","volume":"4","author":"Niewczas","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib89","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib90","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1681\/ASN.2011060628","article-title":"Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes","volume":"23","author":"Gohda","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2013.10.048_bib91","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.2337\/dc12-2521","article-title":"Baseline markers of inflammation are associated with progression to macroalbuminuria in type 1 diabetic subjects","volume":"36","author":"Lopes-Virella","year":"2013","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib92","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12265-012-9387-2","article-title":"Oxidative stress, Nox isoforms and complications of diabetes\u2014potential targets for novel therapies","volume":"5","author":"Sedeek","year":"2012","journal-title":"J\u00a0Cardiovasc Transl Res"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib93","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s00125-002-0831-8","article-title":"Urinary excretion of 8-oxo-7, 8-dihydro-2\u2032-deoxyguanosine as a predictor of the development of diabetic nephropathy","volume":"45","author":"Hinokio","year":"2002","journal-title":"Diabetologia"},{"issue":"10","key":"10.1053\/j.ajkd.2013.10.048_bib94","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3109\/10715762.2012.710902","article-title":"Comparison of 8-hydroxy-2\u2032-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy","volume":"46","author":"Serdar","year":"2012","journal-title":"Free Radic Res"},{"issue":"2 suppl 2","key":"10.1053\/j.ajkd.2013.10.048_bib95","first-page":"54","article-title":"Prevalence of diabetes mellitus and correlation of urinary transforming growth factor-beta1 with blood hemoglobin A1C in the Atascosa Diabetes Study","volume":"18","author":"Riojas","year":"2008","journal-title":"Ethn Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2013.10.048_bib96","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/ki.2011.224","article-title":"Oral cholecalciferol decreases albuminuria and urinary TGF-beta1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition","volume":"80","author":"Kim","year":"2011","journal-title":"Kidney Int"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.048_bib97","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.2337\/diacare.26.9.2632","article-title":"Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy","volume":"26","author":"Gilbert","year":"2003","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2337\/diacare.29.01.06.dc05-1670","article-title":"Urinary connective tissue growth factor excretion correlates with clinical markers\u00a0of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy","volume":"29","author":"Nguyen","year":"2006","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib99","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.2337\/dc07-2469","article-title":"Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy","volume":"31","author":"Nguyen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1053\/j.ajkd.2013.10.048_bib100","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1475-2840-11-42","article-title":"The CTGF gene-945 G\/C polymorphism is not associated with cardiac or kidney complications in subjects with type 2 diabetes","volume":"11","author":"Patel","year":"2012","journal-title":"Cardiovasc Diabetol"},{"key":"10.1053\/j.ajkd.2013.10.048_bib101","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-5751-10-4","article-title":"The CTGF-945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes","volume":"10","author":"Dendooven","year":"2011","journal-title":"J\u00a0Negat Results Biomed"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib102","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.0954-6820.1985.tb08880.x","article-title":"Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate","volume":"218","author":"Grubb","year":"1985","journal-title":"Acta Med Scand"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.048_bib103","first-page":"61","article-title":"Estimating glomerular filtration rate in diabetes using serum cystatin C","volume":"32","author":"MacIsaac","year":"2011","journal-title":"Clin Biochem Rev"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib104","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1681\/ASN.2004100854","article-title":"Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study","volume":"16","author":"Perkins","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib105","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc07-1588","article-title":"Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes","volume":"31","author":"Premaratne","year":"2008","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1053\/j.ajkd.2013.10.048_bib106","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2337\/dc11-2220","article-title":"Serum concentration of cystatin C and risk of end-stage renal disease in diabetes","volume":"35","author":"Krolewski","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.ajkd.2012.11.044","article-title":"Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy","volume":"62","author":"Pavkov","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib108","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1046\/j.1523-1755.1999.00721.x","article-title":"The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?","volume":"56","author":"Gilbert","year":"1999","journal-title":"Kidney Int"},{"issue":"10","key":"10.1053\/j.ajkd.2013.10.048_bib109","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ki.2010.554","article-title":"Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy","volume":"79","author":"Nielsen","year":"2011","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2013.10.048_bib110","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ki.2012.218","article-title":"Measuring urinary tubular biomarkers in type 2 diabetes does not add prognostic value beyond established risk factors","volume":"82","author":"Conway","year":"2012","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib111","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2337\/dc10-1392","article-title":"Clinical significance of urinary liver-type fatty acid-binding protein in diabetic nephropathy of type 2 diabetic patients","volume":"34","author":"Kamijo-Ikemori","year":"2011","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib112","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2337\/dc10-1545","article-title":"Glomerular and tubular damage markers are elevated in patients with diabetes","volume":"34","author":"Nauta","year":"2011","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib113","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/dc09-2242","article-title":"Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients","volume":"33","author":"Nielsen","year":"2010","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib114","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2337\/dc12-0849","article-title":"Urinary cystatin C and tubular proteinuria predict progression of diabetic nephropathy","volume":"36","author":"Kim","year":"2013","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib115","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2215\/CJN.04271007","article-title":"High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes","volume":"3","author":"Rosolowsky","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib116","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2337\/dc10-0227","article-title":"High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up","volume":"33","author":"Ficociello","year":"2010","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1053\/j.ajkd.2013.10.048_bib117","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/db09-0014","article-title":"Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study","volume":"58","author":"Hovind","year":"2009","journal-title":"Diabetes"},{"issue":"6","key":"10.1053\/j.ajkd.2013.10.048_bib118","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1093\/ndt\/gfp740","article-title":"Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes Study","volume":"25","author":"Jalal","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/dc11-1346","article-title":"Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function","volume":"35","author":"Zoppini","year":"2012","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1053\/j.ajkd.2013.10.048_bib120","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.111.171488","article-title":"Effect of a\u00a0reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the Reduction of Endpoints in\u00a0Non-Insulin-Dependent Diabetes Mellitus With the Angiotensin II Antagonist Losartan Trial","volume":"58","author":"Miao","year":"2011","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ajkd.2013.10.048_bib121","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s11892-013-0381-0","article-title":"Uric acid lowering to prevent kidney function loss in diabetes: the Preventing Early Renal Function Loss (PERL) allopurinol study","volume":"13","author":"Maahs","year":"2013","journal-title":"Curr Diab Rep"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.048_bib122","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1681\/ASN.2008121233","article-title":"Urinary\u00a0peptidome may predict renal function decline in type 1 diabetes and microalbuminuria","volume":"20","author":"Merchant","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.048_bib123","doi-asserted-by":"crossref","first-page":"e13051","DOI":"10.1371\/journal.pone.0013051","article-title":"Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology","volume":"5","author":"Maahs","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1053\/j.ajkd.2013.10.048_bib124","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease","volume":"9","author":"Good","year":"2010","journal-title":"Mol Cell Proteomics"},{"issue":"12","key":"10.1053\/j.ajkd.2013.10.048_bib125","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.2337\/db12-0348","article-title":"Urinary proteomics for early diagnosis in diabetic nephropathy","volume":"61","author":"Zurbig","year":"2012","journal-title":"Diabetes"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.048_bib126","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00125-012-2755-2","article-title":"A\u00a0urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus","volume":"56","author":"Roscioni","year":"2013","journal-title":"Diabetologia"},{"issue":"2","key":"10.1053\/j.ajkd.2013.10.048_bib127","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2215\/CJN.04250510","article-title":"FGF-23 as a predictor of renal outcome in diabetic nephropathy","volume":"6","author":"Titan","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2013.10.048_bib128","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/dc10-0199","article-title":"Association between urinary type IV collagen level and deterioration of renal function in type 2 diabetic patients without overt proteinuria","volume":"33","author":"Araki","year":"2010","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1053\/j.ajkd.2013.10.048_bib129","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/ndt\/15.9.1379","article-title":"Urinary excretion of podocytes in patients with diabetic nephropathy","volume":"15","author":"Nakamura","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1053\/j.ajkd.2013.10.048_bib130","doi-asserted-by":"crossref","first-page":"e20431","DOI":"10.1371\/journal.pone.0020431","article-title":"Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy","volume":"6","author":"Zheng","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1053\/j.ajkd.2013.10.048_bib131","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1681\/ASN.2011050485","article-title":"Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy","volume":"23","author":"Putta","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613014315?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638613014315?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:18:36Z","timestamp":1759457916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638613014315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0272638613014315"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.10.048","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Markers of and Risk Factors for the Development and Progression of Diabetic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2013.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}